These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15831093)

  • 1. +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life.
    Mitchell J; Wolffsohn JS; Woodcock A; Anderson SJ; McMillan CV; Ffytche T; Rubinstein M; Amoaku W; Bradley C
    Health Qual Life Outcomes; 2005 Apr; 3():25. PubMed ID: 15831093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MacDQoL individualized measure of the impact of macular degeneration on quality of life: reliability and responsiveness.
    Mitchell J; Wolffsohn J; Woodcock A; Anderson SJ; Ffytche T; Rubinstein M; Amoaku W; Bradley C
    Am J Ophthalmol; 2008 Sep; 146(3):447-454. PubMed ID: 18547542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL).
    Mitchell J; Bradley C
    Qual Life Res; 2004 Aug; 13(6):1163-75. PubMed ID: 15287282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability, validity and responsiveness of the Greek MacDQoL individualized measure of the impact of macular degeneration on quality of life.
    Marakis TP; Koutsandrea C; Chatzistefanou KI; Tountas Y
    Qual Life Res; 2017 Jan; 26(1):183-191. PubMed ID: 27614659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metric properties of the MacDQoL, individualized macular-disease-specific quality of life instrument, and newly identified subscales in French, German, Italian, and American populations.
    Berdeaux G; Mesbah M; Bradley C
    Value Health; 2011 Jan; 14(1):110-20. PubMed ID: 21211493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of a new measure of quality of life for young people with diabetes mellitus: the ADDQoL-Teen.
    McMillan CV; Honeyford RJ; Datta J; Madge NJ; Bradley C
    Health Qual Life Outcomes; 2004 Nov; 2():61. PubMed ID: 15535888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
    Cahill MT; Banks AD; Stinnett SS; Toth CA
    Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rasch analysis reveals problems with multiplicative scoring in the macular disease quality of life questionnaire.
    Finger RP; Fenwick E; Pesudovs K; Marella M; Lamoureux EL; Holz FG
    Ophthalmology; 2012 Nov; 119(11):2351-7. PubMed ID: 22968142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing between Better and Worse Visual Acuity by Studying the Correlation with Quality of Life in Neovascular Age-Related Macular Degeneration.
    Elshout M; van der Reis MI; de Jong-Hesse Y; Webers CA; Schouten JS
    Ophthalmology; 2016 Nov; 123(11):2408-2412. PubMed ID: 27568997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision-related quality of life in patients suffering from age-related macular degeneration.
    Berdeaux GH; Nordmann JP; Colin E; Arnould B
    Am J Ophthalmol; 2005 Feb; 139(2):271-9. PubMed ID: 15733988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Vision Index: a new method to appraise visual function changes in age-related macular degeneration.
    Piermarocchi S; Varano M; Parravano M; Oddone F; Sartore M; Ferrara R; Sera F; Virgili G
    Eur J Ophthalmol; 2011; 21(1):55-66. PubMed ID: 20640999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships Between Measures of the Ability to Perform Vision-Related Activities, Vision-Related Quality of Life, and Clinical Findings in Patients With Glaucoma.
    Ekici F; Loh R; Waisbourd M; Sun Y; Martinez P; Nayak N; Wizov SS; Hegarty S; Hark LA; Spaeth GL
    JAMA Ophthalmol; 2015 Dec; 133(12):1377-85. PubMed ID: 26425961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment satisfaction of patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor agents.
    Marakis TP; Koutsandrea C; Chatzistefanou KI; Tountas Y
    Int Ophthalmol; 2018 Apr; 38(2):565-576. PubMed ID: 28285389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
    Cahill MT; Stinnett SS; Banks AD; Freedman SF; Toth CA
    Ophthalmology; 2005 Jan; 112(1):144-51. PubMed ID: 15629835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life and utility in patients with age-related macular degeneration.
    Sahel JA; Bandello F; Augustin A; Maurel F; Negrini C; Berdeaux GH;
    Arch Ophthalmol; 2007 Jul; 125(7):945-51. PubMed ID: 17620576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
    Revicki DA; Rentz AM; Harnam N; Thomas VS; Lanzetta P
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):712-7. PubMed ID: 19797233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version.
    Suzukamo Y; Oshika T; Yuzawa M; Tokuda Y; Tomidokoro A; Oki K; Mangione CM; Green J; Fukuhara S
    Health Qual Life Outcomes; 2005 Oct; 3():65. PubMed ID: 16248900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration.
    Orr P; Rentz AM; Margolis MK; Revicki DA; Dolan CM; Colman S; Fine JT; Bressler NM
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3354-9. PubMed ID: 21282568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools.
    Finger RP; Fleckenstein M; Holz FG; Scholl HP
    Qual Life Res; 2008 May; 17(4):559-74. PubMed ID: 18365767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric Validation of the National Eye Institute Visual Function Questionnaire - 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma.
    Nordmann JP; Viala M; Sullivan K; Arnould B; Berdeaux G
    Pharmacoeconomics; 2004; 22(3):197-206. PubMed ID: 14871166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.